共 110 条
[1]
Zhang J(2020)Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? Liver Int 40 496-508
[2]
Lin S(2022)Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia Liver Int 42 1981-1990
[3]
Jiang D(2018)Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model Hepatol Int 12 438-446
[4]
Yang M(2022)NAFLD and HBV interplay-related mechanisms underlying liver disease progression Front Immunol 13 965548-508
[5]
Wei L(2017)Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs Front Med 11 502-209
[6]
Hu D(2020)A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement J Hepatol 73 202-1030
[7]
Wang H(2017)Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis J Hepatol 66 1022-3983
[8]
Wang H(2021)Chronic hepatitis B infection with concomitant hepatic steatosis: current evidence and opinion World J Gastroenterol 27 3971-1367
[9]
Tourkochristou E(2011)Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients J Gastroenterol Hepatol 26 1361-540
[10]
Assimakopoulos SF(2012)Hepatitis B virus infection and fatty liver in the general population J Hepatol 56 533-806